DRDO nod for Mankind Pharma to make, market anti-Covid drug 2-DG
New Delhi, July 8 : The Defence Research and Development Organisation (DRDO) has given Mankind Pharma the license to manufacture and market the oral 2-deoxy-D-glucose (2-DG) for the treatment of Covid-19, the pharmaceutical company said on Thursday.M…